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The mouse prostate gland develops by branching morphogenesis from the urogenital epithelium and mesenchyme. Androgens and
developmental factors, including FGF10 and SHH, promote prostate growth (Berman, D.M., Desai, N., Wang, X., Karhadkar, S.S., Reynon, M.,
Abate-Shen, C., Beachy, P.A., Shen, M.M., 2004. Roles for Hedgehog signaling in androgen production and prostate ductal morphogenesis. Dev.
Biol. 267, 387–398; Donjacour, A.A., Thomson, A.A., Cunha, G.R., 2003. FGF-10 plays an essential role in the growth of the fetal prostate. Dev.
Biol. 261, 39–54), while BMP4 signaling from the mesenchyme has been shown to suppresses prostate branching (Lamm, M.L., Podlasek, C.A.,
Barnett, D.H., Lee, J., Clemens, J.Q., Hebner, C.M., Bushman, W., 2001. Mesenchymal factor bone morphogenetic protein 4 restricts ductal
budding and branching morphogenesis in the developing prostate. Dev. Biol. 232, 301–314). Here, we show that Bone Morphogenetic Protein 7
(BMP7) restricts branching of the prostate epithelium. BMP7 is expressed in the periurethral urogenital mesenchyme prior to formation of the
prostate buds and, subsequently, in the prostate epithelium. We show that BMP7lacZ/lacZ null prostates show a two-fold increase in prostate
branching, while recombinant BMP7 inhibits prostate morphogenesis in organ culture in a concentration-dependent manner. We further explore
the mechanisms by which the developmental signals may be interpreted in the urogenital epithelium to regulate branching morphogenesis. We
show that Notch1 activity is associated with the formation of the prostate buds, and that Notch1 signaling is derepressed in BMP7 null urogenital
epithelium. Based on our studies, we propose a model that BMP7 inhibits branching morphogenesis in the prostate and limits the number of
domains with high Notch1/Hes1 activity.
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The prostate is a sex-accessory exosecretory gland in
mammalian males. The prostate retains the ability to support
cell replication, differentiation and morphogenesis throughout
adult life, and is prone to benign and malignant tumors (for
review see Abate-Shen and Shen, 2000; Marker et al., 2003).
The prostate develops by branching morphogenesis from the
epithelium and mesenchyme of the urogenital sinus, an
enlarged portion of the urethra beneath the bladder. Prostate
morphogenesis begins around embryonic day 16 (E16) in0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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urogenital sinus epithelium at particular dorso-ventral and
anterior–posterior positions (Abate-Shen and Shen, 2000;
Marker et al., 2003; and this report). At E16–E19, prostate
buds extend through the urogenital sinus mesenchyme by
proliferation of the ductal epithelium. Postnatally, prostate
lobes grow in size, canalize and undergo lobe-specific
branching. The adult prostate in mouse and human is
composed of branched ducts, made of stratified epithelium,
separated by the basal lamina from the fibroblast stroma and
smooth muscle (for review see Abate-Shen and Shen, 2000;
Marker et al., 2003). There is some evidence pointing to the
relationship between the cell fate choice and morphogenesis in
the prostate. The luminal layer of the epithelium in the adult
prostate contains mostly androgen-dependent secretory cells88 (2005) 334 – 347
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basal epithelial layer may contain epithelial progenitors at
various stages of differentiation (Robinson et al., 1998; Wang
et al., 2001; Tsujimura et al., 2002). Interestingly, cell
proliferation in the prostate epithelium is concentrated to the
distal tips, while the proximal areas of the ducts have been
suggested to contain neuroendocrine androgen-independent
cells, which may contribute to neuroepithelial prostate cancers
(Abate-Shen and Shen, 2000; Foster et al., 2002; Hu et al.,
2002; Marker et al., 2003).
Branching morphogenesis and differentiation of the mouse
prostate depends on the signaling between the urogenital
mesenchyme and epithelium mediated in part by androgens,
Sonic hedgehog (SHH), Fibroblast Growth Factor 10 (FGF10)
and Bone Morphogenetic Protein 4 (BMP4) (Berman et al.,
2004; Donjacour et al., 2003; Freestone et al., 2003; Podlasek
et al., 1999; Lamm et al., 2001). In FGF10 null mice, the
prostates and other sex-accessory glands are either absent or
rudimentary (Donjacour et al., 2003). SHH signaling from the
prostate epithelium, mediated by the Gli1,2,3 transcription
factors in the prostate mesenchyme, is required for prostate
growth and branching (Berman et al., 2004; Freestone et al.,
2003; and our unpublished data). Conversely, haploinsuffi-
ciency for BMP4 has been shown to increase prostate
branching (Lamm et al., 2001), while the BMP12/GDF7 is
required for morphogenesis and differentiation of the seminal
vesicles (Settle et al., 2001). We show that another member of
the BMP family of ligands, BMP7, is expressed dynamically in
the urogenital mesenchyme and prostate epithelium during
prostate development. Here, we implemented gain and loss of
function approaches to show that BMP7 signaling inhibits
prostate branching.
The mechanisms by which the developmental signals are
translated in the epithelium to initiate branching are not well
understood. Recent studies have shown that signaling from the
mesenchyme by FGF10 and BMP4 can modulate Notch1
activity in the epithelium during morphogenesis of the tooth
bud and the pancreas (Hart et al., 2003; Mustonen et al., 2002;
Norgaard et al., 2003). Studies of branching morphogenesis in
the lung and submandibular gland (Hogan, 1999; Jaskoll et al.,
2002) suggest that formation of the new epithelial bud begins
with definition of a domain in the epithelium and adjacent
mesenchyme that is committed to diverge from the main lobe
and form a new branch. Indeed, one of the few evolutionary
conserved mechanisms suggested to mediate formation of
morphogenetic domains, is the Notch–Notch ligand cell fate
selection/lateral inhibition pathway (Anderson et al., 1997;
Artavanis-Tsakonas et al., 1999). For instance, in chick, Notch
signaling has been shown to define positions and boundaries of
the feather buds (Crowe et al., 1998). Notch signaling is
activated by binding of the extracellular domain of the Notch
receptor to its ligands, Delta-like 1 (Dll1) or Jagged1,2
(Jag1,2), themselves membrane receptors (Artavanis-Tsakonas
et al., 1999; Small et al., 2001). In addition, interaction
between Notch and Delta ligands is potentiated by Fringe
glycosyltransferases (Artavanis-Tsakonas et al., 1999). Activa-
tion of the Notch receptor results in proteolytic cleavage andnuclear translocation of the Notch cytoplasmic domain, binding
to the co-transactivator (RBPjk, Supressor of Hairless, Lag-1)
and induction of downstream transcriptional repressors (Hes,
Hairy/Enhacer of Split) (Tomita et al., 1996; Ohtsuka et al.,
1999). In vertebrates, Hes1,5 functions downstream of Notch
signaling to repress transcription of the proneural basic helix–
loop–helix (bHLH) transcription factors, Mash1, Math1 and
Ngn. In vertebrates, Notch signaling has been implicated in
proximal–distal patterning and differentiation of the epithelium
during branching morphogenesis in the mouse lung (Post et al.,
2000; Ito et al., 2000), gut (de Santa Barbara et al., 2003) and
pancreas (Hart et al., 2003; Norgaard et al., 2003). Math1 and
Ngn3 mark differentiation of the proximal neuroendocrine
epithelium in the intestine and pancreas (Gradwohl et al., 2000;
Murtaugh et al., 2003; Yang et al., 2001). During branching
morphogenesis in the lungs, domains of Mash1 expression
coincide with Dll1 in the proximal and interbud regions of the
lung epithelium (Post et al., 2000; Ito et al., 2000). Mash1 has
been also detected in part of the neuroendocrine epithelium
during normal development of the prostate gland and in
prostate cancers (Hu et al., 2002).
In the present study, we explored the interaction between
BMP7 and Notch1 signaling during branching morphogenesis
of the mouse prostate gland. We found that BMP7 is expressed
in the periurethral mesenchyme prior to prostate formation in
embryogenesis, and that BMP7 null prostates exhibit abnor-
mally extensive branching. Conversely, recombinant BMP7
inhibited branching morphogenesis and Hes1 expression in
cultured urogenital explants. Our analysis revealed that
domains of Notch1 activity are localized to the forming buds
and distal prostate tips, and are complementary to BMP/
pSmad1 signaling. Furthermore, areas of Notch1 activity were
significantly broadened in BMP7 null prostates where BMP/
pSmad1 signaling is abolished in the urogenital epithelium.
Based on our data, we propose a model thereby the Notch
selection system is involved in defining the prebud epithelium,
and BMP7 restricts prostate branching by limiting the number
of domains with high Notch1 activity.Materials and methods
Mouse lines, tissue collection and genotyping
Mice strains used were 129SvE BMP7lacZ, a gift from Elizabeth Robertson
(Godin et al., 1998), and Swiss Webster (Taconic, Germantown, NY).
Embryonic day 1 (E1) was designated the day when the vaginal plug was
first observed. The day of birth was designated P1. The sex of E14 and E15
embryos was determined by PCR with primers for the Sry gene (Gubbay et al.,
1992). From E16 on, the sex of the embryos was determined by the
characteristic positions of the sexually committed gonads. Genotyping of
heterozygous BMP7lacZ/+ animals was performed by staining a small tail
biopsy for h-galactosidase activity (Godin et al., 1998). BMP7lacZlacZ null
animals were identified by the lack of eyes and polydactyly of the hind limbs
(Jena et al., 1997).
Tyramide-enhanced immunofluorescent analysis (TIF)
Urogenital samples were fixed in 4% PFA for 1 h, dehydrated and
infused with paraffin overnight at 57-C, embedded into blocks at specified
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temperature overnight. On the day of immunostaining, sections were baked
for 1 h at 57-C, cleared in xylene and rehydrated in graded ethanols.
Endogenous peroxidase activity was quenched for 10 min at room
temperature with 3% hydrogen peroxide, followed by antigen retrieval
performed by microwaving in Citrate Buffer for 30 min. Sections were
blocked with 1% TSA kit blocking reagent (Molecular probes) for 1 h at
room temperature, and incubated with primary antibodies diluted in
blocking reagent at 4-C overnight. The next day, sections were rinsed in
PBS 3  10 min, incubated with biotinylated secondary antibodies, rinsed
in PBS 3  10 min followed with incubation with streptavidin-HRP for 1
h at room temperature, rinsed 3  10 min in PBS, and labeled with 546
Alexa Fluor Tyramide for 5 min, rinsed 3  10 min in PBS, counterstained
with DAPI, rinsed and mounted with Gel/Mount (Biomeda, M01). Primary
antibodies used were: phospho-Smad1 (Ser463/465) (Cell Signaling) at
dilution 1:100; and cleaved Notch1 (Val1744) at dilution 1:50 (Cell
Signaling). Immunofluorescent analysis for smooth muscle actin (sma)
was performed using sma antibody (clone 1A4, DAKO) at 1:30 and 488
Alexa Fluor secondary antibodies.
In situ hybridization
In situ hybridization analysis was performed on paraffin sections with
modifications (Knecht et al., 1995) as previously described (Parr et al., 1993)
using digoxigenin-labeled antisense RNA probes for BMP7 (0.9 kb), Hes1
(1.4 kb), Notch1 (4 kb), Lunatic Fringe (1.2 kb), Maniac Fringe (1.4 kb),
Radical Fringe (2.1 kb) and Dll1 (0.6 kb). For Hes1, in situ analysis was
also performed with TIF visualization of digoxigenin antibodies.
RT-PCR analysis
For RT-PCR analysis, total RNAwas isolated from urogenital sinus samples
by RNAgents Total RNA Isolation System (Promega) according to manufac-
ture’s protocol. Template RNA pools were pretreated with DNAse I and
processed for RT-PCR using SuperScript One-Step RT-PCR kit (Invitrogen).
PCR reactions were performed in a 12.5 Al volume with 50 ng of template and
50 ng of gene specific sense and antisense primer per reaction, under the
following cycling conditions: 45-C for 30 min, 94-C for 2 min; 30 cycles: 94-C
for 15 s, 55-C for 30 s, 68-C for 40 s; 72-C for 7min. For semi-quantitative RT-
PCR analysis, the levels of expression of the target genes were normalized to
the levels of the ubiquitously expressed ribosomal subunit RPL-19. Gene
specific primers used were: for mouse RPL-19 yielding a 556 bp product and
Alk6 yielding a 292 bp product (Lamm et al., 2001); for mAlk2, sense, 5V-
GGAAAGTTGTCTGTGTGGAT-3V, antisense, 5V-TCTGTTCTGACAAC-
CAGTCA-3V yielding a 283 bp product; for mAlk3, sense, 5V-ATTGAAAAT-
CAGAGCCTTCA-3V, antisense, 5V-CAGACTTGGACCAGAAGAAG-3V
yielding a 219 bp product; for mNotch1, sense, 5V-CCATCCTTACAGGAAC-
CATA-3V, antisense, 5V-TACTGTGAAATCAACACGGA-3V yielding a 293 bp
product; for mDll1, sense, 5V-GCAGGTACAGGAGAAGTCGT-3V, antisense,
5V-GCTTCTATGGCAAGGTCTGT-3V yielding a 339 bp product; mJag1,
sense, 5V-GCTGGCAATCAGATTCTTAC-3V, antisense, 5V-AACATCGAT-
GACTGTTCTCC-3V yielding a 180 bp product; and for mJag2, sense, 5V-
CGTGAATATGACCACTTCCT-3V; antisense, 5V-GACTCTTTCTCCTG-
CATCTG-3V yielding a 297 bp product.
Explant cultures
Explants of embryonic and postnatal urogenital sinus were dissected in PBS
and grown on 0.4 Am filters in 12 mm Transwell Plates (Corning Incorporated)
in defined DMEM/F12 (1:1) medium supplemented with 2% ITS (12.5 Ag/ml
insulin, 12.5 Ag/ml trasferrin, 12.5 ng/ml selenious acid, 2.5 mg/ml bovine
serum albumin, 0.7 Ag/ml linoleic acid, Collaborative Biomedical Products);
non-essential amino acids (Gibco); 1% antibiotic–antimycotic (100 units/ml
penicillin, 100 Ag/ml streptomycin, 0.25 Ag/ml amphoteracin (Gibco)) and with
108 M R1881 androgen analog (Sigma). Recombinant human BMP7 and
FGF10 were obtained from R&D Systems Inc. (Minneapolis, MN). Medium
was replaced every 36 h.To separate the epithelium and mesenchyme, the urogenital sinus tissue
was treated with 2.5% trypsin, 0.5% pancreatin in Tyrode solution (Weaver
et al., 2000) for 30 min at room temperature, then neutralized with 10%
FBS in DMEM/F12 for 30 min on ice. Distal and proximal mesenchyme,
and the epithelium of the urogenital sinus were teased away with tungsten
needles.
Results
BMP7 is expressed dynamically during prostate development
BMP7lacZ reporter strain has been made and used
previously for analysis of BMP7 expression and function in
the ureteric bud and nephrogenic mesenchyme during
development of the kidney (Godin et al., 1998; Dudley et
al., 1999). Our analysis of the lower urogenital system in
BMP7lacZ/+ mice uncovered that BMP7 is expressed in all
lobes of the mouse prostate gland: the anterior (AP), dorso-
lateral (DLP) and ventral (VP) prostates (Figs. 1E–G). We
confirmed, using BMP7 probe by whole mount in situ
hybridization of wild type urogenital sinus, that BMP7lacZ
expression reflects that of the endogenous gene (not shown).
BMP7lacZ/+ mice develop normally (Godin et al., 1998 and
our data) and BMP7lacZ/+ heterozygous prostates are mor-
phologically and histologically indistinguishable from wild
type. Thus, further analysis of BMP7 expression during
development of the mouse prostate gland was carried out in
the BMP7lacZ reporter strain by staining for h-galactosidase
activity (Godin et al., 1998). To better understand morpho-
genesis of the prostate, we defined the following stages in
prostate development, similar to those described for the
submandibular gland (Jaskoll et al., 2002): E16–E17,
formation of the prebud placodes of the prostate as thickened
domains of the urogenital epithelium (Fig. 2A); E17,
formation of the initial buds as invaginations of the prebud
placodes into mesenchyme (Figs. 2A, B); E17–E19, exten-
sion of the initial buds through the mesenchyme (Fig. 1C);
E19–P1, pseudoglandular stage—formation of stratified
epithelium; P1, formation of the ductal canal (canalization)
and initiation of postnatal branching (Fig. 1D). We found that
low levels of BMP7lacZ are first detectable in the urogenital
sinus mesenchyme at E15 (Fig. 1A), i.e. about 48 h prior to
the appearance of the first initial buds at E17 (Figs. 2A, B).
At E17, BMP7lacZ is upregulated in the urogenital mesen-
chyme, in particular in the dorsal area (Fig. 1B). Analysis of
transverse sections shows that at E17 thickening of the
urogenital epithelium is seen along the mesenchymal–
epithelial boundary (Fig. 2A, arrowhead), suggesting forma-
tion of the prebud placodes. At E17, BMP7lacZ expression is
concentrated to a narrow layer of mesenchyme immediately
adjacent to the multilayered pseudostratified urogenital sinus
epithelium (Figs. 2A–D). At E17, the initial buds invaginate
into mesenchyme (Fig. 2A, arrows). Interestingly, during
formation of the initial buds, BMP7lacZ expression is
significantly reduced in the mesenchyme immediately adja-
cent to the bud tips (Fig. 2A, arrows). Notably, BMP7lacZ is
not expressed in the urothelium at any stages in embryogen-
esis (Figs. 2A–C and data not shown) or postnatally (Fig. 2E
Fig. 1. BMP7lacZ expression during prostate development. (A–C) Embryonic BMP7lacZ/+ male urogenital sinus stained whole mount for h-galactosidase activity (A)
at E15, (B) at E17, (C) at E18. (D) BMP7lacZ/+ urogenital sinus at P1 processed as in panels A–C. (A) At E15, BMP7lacZ expression is first detectable in the
periurethral mesenchyme. (B) At E17, BMP7lacZ is strongly expressed in the urogenital mesenchyme, and appears in the epithelium of the seminal vesicles. (C) At
E18, BMP7lacZ is upregulated at the bud tips (arrowheads), and is low or absent at the bud stalks (arrows). (D) At P1, BMP7lacZ is expressed in the prostate
epithelium and in the urogenital sinus mesenchyme. (E–I) BMP7lacZ expression in postnatal BMP7lacZ/+ anterior prostate at P3 (I) and male urogenital system at P7
(E–G): (E) dorsal view, (F) lateral view, (G) ventral view. BMP7lacZ is expressed in the epithelium and mesenchyme of the anterior (E, F, I), dorso-lateral (E, F) and
ventral prostates (G); in the epithelium of the Vas Deferens, epididymus and seminal vesicles (E); and in the urethra (E, G). (I) Normal branching pattern in P3
BMP7lacZ/+ heterozygous anterior prostate. (J) Branching of P3 BMP7lacZ/lacZ null anterior prostate is increased two-fold compare to heterozygous littermate (I).
Abbreviations: UGS, urogenital sinus; UGM, urogenital sinus mesenchyme; d, dorsal; v, ventral; Bl, bladder; SV, seminal vesicles; AP, anterior prostate; DLP, dorso-
lateral prostate; VP, ventral prostate; VD, Vas Deferens; d, epididymus; T, testis; Ur, urethra.
I.B. Grishina et al. / Developmental Biology 288 (2005) 334–347 337and data not shown). BMP7lacZ is not detectable in the
prostate epithelium at the initial stages of morphogenesis, i.e.
at the prebud (Fig. 2A, arrowhead) and the initial bud stages
(Fig. 2A, arrows). Weak BMP7lacZ expression first appears in
the prostate epithelium as the initial buds begin to extend
(Fig. 2B, arrows) followed by upregulation at the prostate tips
(Fig. 2B, arrowheads). Whole mount analysis of E18
urogenital sinus (Fig. 1C) shows high BMP7lacZ expressionat the tips of the extending initial buds of the anterior, ventral
and dorso-lateral prostates (Fig. 1C, arrows). BMP7lacZ
expression is initially low at the bud stalks (Fig. 1C,
arrowhead). Following upregulation at the epithelial tips,
BMP7lacZ expression spreads proximally to the stalks within
24 h (compare Figs. 1C, D). In the postnatal prostate,
BMP7lacZ is expressed in the epithelium in all prostate lobes
(Figs. 1E–G). As during prostate formation in embryogene-
Fig. 2. BMP7lacZ expression in the prostate epithelium andmesenchyme. Paraffin sections ofBMP7lacZ/+ male urogenital sinus at E17 (A–D) and P5 (E, F) were stained
with X-gal, and immunostained with a-smooth muscle actin (sma) (D, F). Planes of sections are indicated in the whole mount images below each panel. (A, B)
Transverse section of E17 BMP7lacZ/+ urogenital sinus. (A) BMP7lacZ is expressed in the periurethral mesenchyme and absent from urothelium. Areas of thickened
epithelium (prebud placodes) form along the epithelial–mesenchymal boundary (arrowhead). BMP7lacZ is reduced in the mesenchyme adjacent to the initial buds
(arrows). (B) Low levels of BMP7lacZ appear in the prostate epithelium at the extending initial bud stage (arrows). BMP7lacZ is upregulated at the extending prostate tips
(arrowheads). (C, D) Sagittal section of BMP7lacZ/+ E17 urogenital sinus. BMP7lacZ-positive periurethral mesenchyme is separated from the myoblasts expressing
smooth muscle actin (sma) by 4–6 layers of BMP7lacZ-negative mesenchyme (arrowheads in panel D). (E, F) Transverse section ofBMP7lacZ/+ postnatal prostate at P5.
(E) BMP7lacZ is upregulated in the epithelium of prostate tips (arrowheads). BMP7lacZ is maintained in the proximal mesenchyme (arrows). (F) Myoblasts expressing
sma are localized adjacent to the distal prostate tips (arrowheads). In the areas proximal to the urethra, myoblasts are separated from the prostate ducts by BMP7lacZ-
positive (arrows) and BMP7lacZ-negative mesenchyme. Scale bar, 20 Am for (A–D); 100 Am for (E, F).
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the distal tips (Figs. 1I, 2E).
BMP7 expression in the mouse prostate differs from that
of the seminal vesicles, also exosecretory gland in mouse,
which develops adjacent to the anterior prostate (Figs. 1E,
F). In the seminal vesicles, BMP7lacZ expression appears in
the epithelium at E17 (Fig. 1B), is present transiently at the
epithelial tips during postnatal branching (Figs. 1E, F) and
is absent by 3 weeks of age (data not shown). In contrast,
in the prostate, BMP7lacZ expression in the epithelium
persists into adulthood (assayed up to 18 months of age,
data not shown). In addition, BMP7 is not expressed in the
mesenchyme of the seminal vesicles (Fig. 1B). Those
differences in BMP7 expression may potentially reflect the
different origin of the prostate and seminal vesicles: prostate
epithelium and mesenchyme are derived from the urogenital
sinus, whereas seminal vesicles originate from the Wolfian
ducts.
During development of the lungs, part of BMP4-expressing
mesenchyme undergoes differentiation into smooth muscle
(Weaver et al., 2003). In contrast, we found that BMP7 is
excluded from differentiating myoblasts during prostate forma-
tion in embryogenesis (Fig. 2D) and during postnatal develop-ment (Fig. 2F). Analysis of BMP7lacZ and a-smooth muscle
actin (sma) expression in E17 male urogenital sinus (Figs. 2C,
D) showed that BMP7lacZ-positive periurethral mesenchyme is
continuous antero-posteriorly along the urethra and is separated
by LacZ-negative mesenchyme from the sma-positive myo-
blasts in the distal mesenchyme. Thus, only a subpopulation of
sma-negative fibroblasts closest to the epithelium expresses
BMP7lacZ (Figs. 2C, D). In the postnatal prostate, BMP7lacZ
expression is maintained in the mesenchyme proximally to the
urethra (Figs. 2E, F, arrows) and absent near the distal prostate
tips (Figs. 2E, F, arrowheads). Notably, at the distal tips, smooth
muscle differentiates immediately adjacent to the ductal
epithelium (Fig. 2F, arrowheads).
BMP7 null anterior prostates show excessive branching
To address the function of BMP7 during prostate develop-
ment, we analyzed branching morphogenesis in BMP7lacZ/lacZ
null (Figs. 1J, 4F–H) and normal BMP7lacZ/+ heterozygous
prostates (Figs. 1I, 4D, E). Most BMP7lacZ/lacZ homozygous
mice die soon after birth due to severe defects in nephrogenesis
leading to kidney failure. Yet, 7–10% of BMP7lacZ/lacZ
newborns survive up to 10 days (Godin et al., 1998 and our
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(Fig. 1I) and BMP7lacZ/lacZ homozygous prostate lobes (Fig.
1J) stained in whole mount with X-Gal to visualize prostate
epithelium. We found that lack of functional BMP7 allele
resulted in significant increase in the number of distal tips and
branching points in the anterior prostate of BMP7lacZ/lacZ null
mice (compare Figs. 1I and J). The mean number of distal tips
increased from 12 T 2 (mean T SEM, n = 8) in P3 BMP7lacZ/+
heterozygous prostate lobes to 25 T 3 (mean T SEM, n = 8) in
P3 BMP7lacZ/lacZ homozygous prostate lobes. In addition,
BMP7lacZ/lacZ homozygous anterior prostates showed distinct
changes in the branching pattern. At P3, wild type and
BMP7lacZ/+ heterozygous anterior prostates are composed of
a single main trunk with non-branched secondary buds (Fig.
1I). In contrast, BMP7lacZ/lacZ null prostates undergo extensive
secondary and tertiary branching at early postnatal stages
acquiring a more bulky and branched ductal structure (Fig. 1J).
Thus, we conclude that BMP7 signaling functions to inhibit
prostate branching during normal development.Fig. 3. BMP7 inhibits branching morphogenesis and Hes1 expression in prostate exp
a dose-dependent manner. P1 BMP7lacZ/+ urogenital sinus explants were cultured
control. (B–D) Recombinant human BMP7 (R&D Systems) was added at: (B) 50 ng
lateral prostate. (E) Graphic representation of six experiments. The curve is drawn th
urogenital sinus. Explants of E17 male urogenital sinus were cultured for 60 h in the
(300 ng/ml) combined with FGF10 (100 ng/ml) (lanes 5, 6). Levels of Hes1 expres
PCR analysis. Levels of ubiquitously expressed ribosomal subunit RPL-19 (lanes
inhibited Hes1 expression in cultured prostates (compare lanes 2 and 4). Addition o
(compare lanes 2 and 6).BMP7 inhibits branching morphogenesis in prostate explants
To complement BMP7 loss-of-function studies, we investi-
gated the effect of gain of BMP7 function in prostate in explant
cultures. BMP7lacZ/+ urogenital explants were isolated at P1
and cultured for 4 days in the absence or presence of
recombinant BMP7 at 50, 100 and 300 ng/ml (Figs. 3A–D).
We found that BMP7 inhibited formation of prostate buds in a
dose-dependent manner (Figs. 3A–D, E). Growth of explants
in defined medium without BMP7 treatment resulted in
formation of six buds of each dorso-lateral (Fig. 3A) and
ventral (not shown) prostate lobes, and a pair of anterior
prostate tips (not shown). Treatment with BMP7 at 50 ng/ml
resulted in 50% decrease in the number of total prostate buds
(Fig. 3E, n = 6). Among those, we observed three to four
dorso-lateral prostate tips (Fig. 3B), two to three ventral
prostate tips and one or none anterior prostate lobes (not
shown). Growth of seminal vesicles was not affected (Figs.
3B–D). At 100 ng/ml of BMP7 in the medium, only a singlelants. (A–E) Recombinant human BMP7 inhibits formation of prostate buds in
for 4 days in defined medium (see Materials and methods). (A) Non-treated
/ml, (C) 100 ng/ml, (D) 300 ng/ml. Arrows are pointing to the buds of the dorso-
rough the mean T SME interval. (F) BMP7 inhibits Hes1 expression in cultured
absence (lanes 1, 2) and in presence of BMP7 (300 ng/ml) (lanes 3, 4); or BMP7
sion in the explants (lanes 2, 4 and 6) were compared by semi-quantitative RT-
1, 3 and 5) are shown for semi-quantitative reference. Treatment with BMP7
f FGF10 counteracted inhibitory effect of BMP7 and restored Hes1 expression
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shown) and anterior (Fig. 3C) prostate tips formed. At 300 ng/
ml of BMP7 in the medium, dorso-lateral prostate failed to
form (Fig. 3D), although a single ventral and anterior prostate
bud was observed (in four of six experiments). We conclude,
that increased BMP7 signaling inhibited branching morpho-
genesis in urogenital sinus explants.
BMP7 inhibits Hes1 expression in urogenital sinus explants
Recent studies have suggested that Notch activity during
epithelial morphogenesis can be modulated by FGF and BMP
signaling (Mustonen et al., 2002; Hart et al., 2003). To assay
whether inhibition of branching morphogenesis in the prostate
by BMP7 may be mediated by the Notch1 pathway, we first
investigated the effect of recombinant BMP7 on the level of
Hes1 transcription in cultured embryonic urogenital sinus (Fig.
3F). Explants of E17 urogenital sinus were cultured in the
defined medium alone for control, in the presence of
recombinant BMP7 (300 ng/ml), or the combination of
BMP7 (300 ng/ml) and FGF10 (100 ng/ml), and the levels of
Hes1 mRNA were compared by semi-quantitative RT-PCR
analysis (Fig. 3F). Interestingly, treatment with BMP7 de-
creased Hes1 expression in the explants to trace levels (Fig. 3F,
compare lanes 2 and 4), indicating that BMP7 signaling
inhibited Notch1 activity in the cultured explants. FGF10 has
been shown to support Notch1 activity and Hes1 expression
during morphogenesis of the pancreas, as well as in the tooth
bud (Hart et al., 2003; Norgaard et al., 2003; Mustonen et al.,
2002). We found that, in the urogenital explants, the
combination of BMP7 and FGF10 counteracted the inhibitory
effect of BMP7 and restored Hes1 expression close to control
levels (Fig. 3F, compare lanes 2 and 6). Treatment of explants
with FGF10 alone had no detectable effect on the levels of
Hes1 expression (not shown). FGF10 expression has been
previously reported in the distal mesenchyme of the urogenital
sinus and prostate, and is required for prostate growth
(Donjacour et al., 2003). Thus, we suggest that the combination
of BMP7 and FGF10 may contribute to regulation of the Notch
pathway during prostate development.
Expression of Notch pathway genes during prostate
development
To define the function of Notch pathway during prostate
development, we analyzed nuclear localization of the cyto-
plasmic domain of the Notch1 receptor (cNotch1) (Figs. 4A
and 5), and expression of the Notch pathway genes in the
embryonic urogenital sinus by section in situ hybridization
(Figs. 4B–H) and semi-quantitative RT-PCR (Fig. 4I). Exam-
ination of sections of E18 urogenital sinus showed that
cNotch1 localizes to the nucleus in the urogenital epithelium
adjacent to the mesenchyme (Fig. 4A). Consistently, expression
of the Notch1 receptor was detected only in the urogenital
epithelium (Figs. 4B, I). Expression of Hes1, the downstream
target of Notch1 was also restricted to the urogenital epithelium
(Figs. 4C, D). In contrast, Notch1 ligands, Dll1 (Figs. 4E, I)and Jag1 (Fig. 4I) were found differentially expressed in the
urogenital epithelium and mesenchyme. In situ hybridization
revealed that Dll1 expression is high in selected cell clusters in
the urogenital epithelium (Fig. 4E). Interestingly, clusters of
cells with high Dll1 expression (Fig. 4E) coincide with areas of
low cNotch1 (Fig. 4A) activity on the adjacent section, and
vise versa. Jag1 expression was also found in the urogenital
mesenchyme and epithelium with highest levels in the
proximal mesenchyme (Fig. 4I). RT-PCR analysis showed that
Jag2 is expressed at trace levels uniformly in the epithelium
and mesenchyme (not shown). Glycosylation of the Notch1
receptor by Fringe glycosyltransferases is known to potentiate
Notch1 interaction with Dll1 and can inhibit Notch1 interaction
with Jag1,2 (Lei et al., 2003; Moloney et al., 2000; Panin et al.,
2002). Our analysis indicates that Lunatic (Fig. 4F), Maniac
(Fig. 4G) and Radical Fringe (Fig. 4H) are all expressed in the
urogenital epithelium with higher levels at the distal epitheli-
um, and are upregulated at the sites of forming prostate buds.
Notably, the areas of highest Fringe expression, in particular
that of Maniac Fringe (Fig. 4G), coincide with domains of
high Notch1 activity (Figs. 4A, F–G). Thus, our analysis
indicates that at the time of prostate formation Notch1 activity
is localized to the discrete epithelial domains adjacent to the
mesenchyme, which are potentially the sites of perspective bud
formation (Fig. 4A). In addition, domains of high Notch1
activity coincide with expression of Fringes (Figs. 4A, F–H),
and are complementary to the domains of high Dll1 expression
(Figs. 4A, E), suggesting the possibility that Notch–Delta
selection mechanism may be involved in defining the positions
of the prostate buds.
Relationship between cNotch1 and pSmad1 activity during
prostate development
BMP7 signaling is mediated by binding to a heteromeric
receptor complex, composed of type II receptors: ActRII or
BmpRII, and type I receptors: Alk2 or Alk6 (Yamashita et al.,
1996). Alk3 has also been shown to bind BMP7, although no
downstream signaling has been recorded (Dewulf et al.,
1995). To determine whether BMP7 specific receptors may
function during prostate development, we assayed the
expression of Alk2, Alk3 and Alk6 by semi-quantitative RT-
PCR in E17 urogenital epithelium, proximal and distal
mesenchyme (Fig. 4I). We found that all three BMP7 binding
receptors are expressed in embryonic urogenital epithelium. In
contrast, only the Alk6 receptor was detected in the proximal
urogenital mesenchyme, whereas Alk2 and Alk3 are expressed
in the distal mesenchyme.
Upon binding to BMP7, activation of the type I receptors
results in phosphorylation and nuclear translocation of the
transcription factor Smad1 (Macacias-Silva et al., 1998). To
define the areas of phospho-Smad1 (pSmad1) signaling during
embryonic and postnatal development of the prostate, we
analyzed nuclear localization of pSmad1 on sections of E18
male urogenital sinus (Fig. 5A), and in P1 and P3 prostate
(Figs. 5D, I). We found that at the time of prostate formation at
E18 pSmad1 is present and localized to the nucleus in the
Fig. 4. Alk and Notch pathway gene expression, and Notch1 activity in the embryonic urogenital sinus. (A) In E18 urogenital sinus, cNotch1 is localized to the nuclei
in the urogenital epithelium adjacent to the mesenchyme. (B–H) In situ hybridization analysis of gene expression with digoxigenin labeled antisense RNA probes
visualized with BM-purple (B, D–H) or tyramide-enhanced fluorescence (C). Expression of Notch1 (B), Hes1 (C, D), Dll1 (E), Lunatic Fringe (F), Maniac Fringe
(G) and Radical Fringe (H) is shown. Scale bar, 50 Am. (I) RT-PCR analysis of expression of Alk receptors, Notch1 and Notch ligands in the whole E17 male
urogenital sinus (UGS), distal mesenchyme (DM), proximal mesenchyme (PM) and urogenital epithelium (Ep). Levels of RPL-19 are shown for semi-quantitative
reference. In the urogenital epithelium, Alk2, Alk3 and Alk6 are expressed. Only Alk6 is expressed in the proximal urogenital mesenchyme. Only Alk2 and Alk3 are
expressed in the distal mesenchyme. Notch1 receptor is expressed only in the urogenital epithelium. Dll1 is expressed at low level in the epithelium and proximal
mesenchyme, and at high level in the distal urogenital mesenchyme. Jag1 is expressed in all compartments, and at highest levels in the proximal mesenchyme.
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Examination of sections of BMP7lacZ/+ E18 urogenital sinus
showed that cNotch1 localizes to the nucleus at the forming
prostate buds (Fig. 5B). Interestingly, overlay of the adjacent
sections showed that both pSmad1 and cNotch1 signaling is
present in the developing prostate buds, however, within
essentially non-overlapping adjacent domains (Fig. 5C,
arrows). Nuclear cNotch1 and pSmad1 localization was
mutually exclusive in 95% of nuclei scored for pSmad1signaling and 85% of nuclei scored for cNotch1 signaling,
which is consistent with our RT-PCR data showing that BMP7
inhibits Notch1/Hes1 pathway in urogenital explants (Fig. 3F).
To determine the distribution of pSmad1 and cNotch1
signaling during postnatal prostate branching, we examined
the sections of BMP7lacZ/+ heterozygous prostates at P1 (Figs.
5D, E) and P3 (Figs. 5I–K). At P1, we detected high levels of
nuclear pSmad1 in selected areas of the urogenital epithelium
(Fig. 5D, ur), proximal mesenchyme (Fig. 5D, pm), as well as in
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smooth muscle. In contrast, cNotch1 was localized to the nuclei
only in the distal prostate tips (Fig. 5E). At P3, pSmad1 signaling
is high in the proximal urogenital epithelium (Fig. 5I, ur), in
selected cell clusters in prostate epithelium (Fig. 5I, arrows) and
in the urogenital mesenchyme (Fig. 5I, m). At P3, cNotch1
signaling was detected in the urogenital epithelium (Fig. 5J, ur),
and in selected clusters in the prostate buds (Fig. 5J, pr, arrows).
Notably, as at earlier stages, domains of pSmad1 and cNotch1
signaling have little or no overlap in P3 prostate (Fig. 5K). Thus,
during postnatal prostate branching as in embryogenesis,
cNotch1 activity is localized to the proximal urothelium and
selected clusters within forming prostate buds and distal tips, and
is excluded from the domains of pSmad1 signaling.
We reported that lack of BMP7 signaling in BMP7lacZ/lacZ
null prostates resulted in significant increase in secondary
and tertiary branching in the anterior prostate lobes (Figs.
1I, J). We further compared the distribution of pSmad1 and
cNotch1 signaling on the sections of P1 BMP7lacZ/lacZ null
(Figs. 5F–H) and BMP7lacZ/+ heterozygous prostates (Figs.
5D, E). Analysis of BMP7lacZ/lacZ null prostates at P1
uncovered significant changes both in pSmad1 (Fig. 5F) and
cNotch1 signaling (Fig. 5G). As expected, pSmad1 signaling
was significantly decreased in BMP7lacZ/lacZ null urogenital
epithelium (Figs. 5F, H), reflecting lack of BMP7 signaling
from the periurethral mesenchyme. Interestingly, pSmad1
signaling persisted in few cell clusters at the distal tips
(Figs. 5F, H), likely reflecting BMP4 signaling in the distal
mesenchyme (Lamm et al., 2001). Interestingly, in
BMP7lacZ/lacZ null prostates, cNotch1 signaling was widely
spread in the urogenital epithelium as well as in multiple
prostate buds (Figs. 5G, H). These results indicate that loss
of functional BMP7 in BMP7lacZ/lacZ null prostates results in
derepression of cNotch1 signaling in urogenital and prostate
epithelium (compare Figs. 5E and G). Thus, we suggest that
cNotch1 signaling is associated with the domains of
urogenital epithelium that are competent to form new
prostate branches, and that BMP7 functions to restrict
prostate branching by limiting the number of domains with
high Notch1 activity.
Discussion
Branching morphogenesis is an ancient repetitive algorithm
of induction and repression of epithelial bud formation which is
used in the development of lungs and all exosecretory glands inFig. 5. pSmad1 and cNotch1 signaling during prostate development. (A–C) Transve
the urogenital epithelium. (B) cNotch1 is localized to the nuclei of the forming pros
epithelium are shown in blue. (D, E) Transverse sections of BMP7lacZ/+ heterozyg
epithelium (ep) and prostate buds (arrows), periurethral mesenchyme (pm) and distal
prostate buds. (F–H) Transverse sections of P1 BMP7lacZ/lacZ null prostate. (F, H)
present in the distal tips. (G, H) cNotch1 signaling is wide spread in the urogenital
Transverse sections of BMP7lacZ/+ heterozygous prostate at P3. (I) pSmad1 is nuc
pSmad1 signaling is also observed in the mesenchyme (m). (J) cNotch1 signaling in
cells in the prostate buds and distal tips, and shows little or no overlap with pSmad1 s
is shown in blue channel (D–G, I–J). Scale bar, 50 Am for sections A–H; 100 Ammammals. Development of epithelial–mesenchymal organs by
branching morphogenesis allows to increase luminal surface,
while retaining compact volume and modular functional
structure. Signaling factors, BMP, FGF and SHH have been
implicated in branching morphogenesis in various organs.
However, how the signaling is interpreted in the epithelium to
define the bud regions is still unclear. We investigated the
function of BMP7 signaling in branching morphogenesis of the
mouse prostate gland, and the interaction between the BMP7
and Notch1 pathways during prostate development. We
combined gain and loss of function approaches to show that
BMP7 inhibits branching morphogenesis in the mouse
prostate, and also interferes with Notch1 pathway in the
urogenital and prostate epithelium. We further show that
high Notch1 activity is associated with forming prostate
buds. Based on our data, we propose a model thereby
during prostate development, BMP7 signaling inhibits
prostate branching, and limits the number of domains with
high Notch1 activity. We discuss the possibility of involve-
ment of the Notch selection system in defining morphoge-
netic domains and/or cell fate choice during branching
morphogenesis.
BMP7 is regulated dynamically during prostate development
Previous studies have shown that BMP7 is expressed in the
ureteric bud and is important for development of the kidney
(Dudley et al., 1995, 1999; Godin et al., 1998). Here, we show
that BMP7 is expressed during development of the male
urogenital sinus, and present evidence that BMP7 contributes
to branching morphogenesis in the prostate gland. The dynamics
of BMP7 expression in the embryonic urogenital sinus provides
the first indication of the importance of BMP7 function in the
prostate development: first, BMP7 is expressed early in
development in the urogenital mesenchyme, at E15, i.e. at least
48 h prior to the initiation of prostate morphogenesis; second, the
initial BMP7 expression is concentrated to a narrow layer of the
urogenital mesenchyme adjacent to the epithelium which
subsequently undergoes branching morphogenesis; and third,
during branching morphogenesis in the prostate, BMP7 expres-
sion dynamically shifts between the adjacent compartments of
the epithelium and mesenchyme, and from the tips to the stalks
of the epithelial ducts. At the beginning of prostate development
at E17, at the prebud stage, BMP7 is not expressed in the
urogenital epithelium, but expression is high in the periurethral
mesenchyme. At the initial bud stage, BMP7 expression isrse sections of E18 BMP7lacZ/+ heterozygous prostate. (A) pSmad1 is nuclear in
tate buds. (C) Overlay of adjacent sections A and B. Outlines of the urogenital
ous prostate at P1. (D) pSmad1 is nuclear in selected areas of the urogenital
mesenchyme (dm). (E) cNotch1 is localized to the nuclei at the distal tips of the
pSmad1 signaling in the urogenital epithelium is significantly reduced, but is
epithelium and prostate buds. (H) Overlay of adjacent sections F and G. (I–K)
lear in selected areas of the urogenital (ur) and prostate epithelium (arrows).
the urothelium (ur) and prostate epithelium (arrows) is localized to clusters of
ignaling (I, K). (K) Overlay of adjacent sections I and J. DAPI staining of nuclei
for sections I–K.
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initial bud stage, BMP7 expression appears in the prostate
epithelium. During the bud extension stage, BMP7 is upregu-lated at the bud tips, and is extended towards the stalks during the
pseudoglandular stage. This dynamic changes in BMP7 expres-
sion may be regulated by short-range ligands signaling between
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sheet. Although the identity of those ligands is currently
unknown, potential candidates include SHH (Podlasek et al.,
1999), the Wnt molecules (Soshnikova et al., 2003; Kuschel et
al., 2003) and androgens (Berman et al., 2004; Thomas et al.,
1998). Upregulation of SHH and its putative downstream
effector, the NKX3.1 homeobox protein, has been reported in
the urogenital and prostate epithelium (Kim et al., 2002;
Podlasek et al., 1999). Yet, in our experiments, recombinant
SHH failed to affect BMP7 expression in cultured urogenital
sinus (our unpublished data). We have also detected nuclear
localized h-catenin in the epithelium of the prostate tips and in
the interbudmesenchyme (our unpublished data), indicating that
Wnt/h-catenin pathway may be important in prostate develop-
ment. We think that androgens are unlikely to regulate BMP7
expression during prostate development, as BMP7 is also
expressed during branching morphogenesis in the female
clitorial gland (our unpublished data). However, it is possible
that androgens may contribute to the maintenance of BMP7
expression in the androgen-dependent prostate epithelium in the
adult, as we have observed continued BMP7 expression in the
prostate at least up to 18 months of age.
BMP7 inhibits branching morphogenesis in the prostate
We have found that loss of functional BMP7 in BMP7lacZ/lacZ
null anterior prostates significantly increases branching. Con-
currently, treatment of explanted urogenital tissue with recom-
binant BMP7 inhibited formation of prostate buds in a dose-
dependent manner. Together, these findings strongly suggest
that BMP7 inhibits formation of the new branching sites in the
urogenital and prostate epithelium. How is BMP7 signaling
translated in the prostate epithelium to limit the number of the
prebud sites? One possibility is that during prostate development
BMP7 signaling is spatially modulated by the BMP extracellular
antagonists, such as follistatin and noggin (Weaver et al., 2003;
Morgan et al., 2003). Expression of follistatin, the major BMP7
antagonist has been detected in the prostate epithelium in
newborn rats (Cancilla et al., 2001), and expression of noggin
has been reported in the penile mesenchyme in mouse (Morgan
et al., 2003). Another possibility is that BMP may function in
branching morphogenesis by affecting cell survival in a context-
dependent manner. For instance, BMP7 signaling is necessary
for survival of the pronephrogeneic mesenchyme during
development of the kidney (Dudley et al., 1999), while BMP7
is required for programmed cell death during development of the
limbs and external genitalia (Katagiri et al., 1998; Morgan et al.,
2003). Indeed, the increased number of prostate buds in BMP7
null mice suggests that lack of BMP7 signaling may favor
selective survival of the epithelial progenitors with particular
morphogenetic fates.
BMP7 inhibits Notch1 pathway in the prostate epithelium
In this study, we explored the relationship between BMP7
signaling and the Notch1 pathway during branching morpho-
genesis in the prostate. We show that high Notch1 activity isspecifically associated with formation of the initial buds in the
prostate in embryogenesis and postnatally. We further show
that recombinant BMP7 inhibits expression of Hes1, the
reporter of Notch1 activity, in prostate organ cultures. On the
other hand, in BMP7 null mice, increased prostate branching
coincided with significant decrease of pSmad1 signaling and
wide spread of Notch1 signaling in the urogenital epithelium.
Together, our data indicate that BMP7 inhibits Notch1 pathway
in the prostate epithelium and limits the number and size of cell
clusters with high Notch1 activity. It is important to point that
our data does not test directly the involvement of Notch1 in
prostate morphogenesis. Although our data shows that Notch1
activity is always associated with forming prostate buds, we
cannot ascertain whether Notch1 pathway may be involved in
prostate morphogenesis directly, for instance in defining the
bud versus interbud regions; or that Notch1 activity might
contribute towards cell fate determination after the bud domain
is defined by a Notch-independent mechanism. Future studies
in our laboratory on Notch1 gain of function during prostate
development using retroviral infections to express activated
form of Notch1; and analysis of the effect of loss of Notch
function in Hes1 mice mutants will provide further evidence on
Notch1 function in cell fate choice and/or branching morpho-
genesis in the prostate gland.
We have found that during postnatal branching, as in
embryogenesis, high Notch1 activity is concentrated to the
prebud epithelium, and the tips of the initial and extending
prostate buds. This suggests that Notch1 pathway functions
similarly during formation of the primary prostate buds, which
originate at defined positions around the urethra; and during
postnatal prostate branching, which occurs semi-randomly.
Since appearance of secondary and tertiary prostate tips is
significantly increased in BMP7 null prostates, it is reasonable
to assume that lack of BMP7 signaling during postnatal
branching results in an environment permissive for formation
of the additional prostate buds. However, we cannot complete-
ly exclude the possibility that it is the lack of BMP7 signaling
earlier, at E14–E17 in embryogenesis, that allows specification
of a larger number of hypothetical bud progenitor cells that
give rise to additional branches postnatally.
Since BMP7 is expressed throughout the periurethral
mesenchyme in the urogenital sinus, our model suggests that
the inhibitory effect of BMP7 is locally downregulated and/or
compensated by another factor for bud outgrowth to begin. The
factors promoting bud extension during branching morpho-
genesis in the prostate may be, for instance, FGF10 or SHH. In
the lungs, FGF10 has been shown to promote budding and
proliferation of the epithelium, and was suggested to compen-
sate for the inhibitory effect of BMP4 in the buds at short-
range; whereas in the interbud regions, the restrictive effect of
BMP4 is thought to predominate at long distance (Hogan,
1999). In the prostate, FGF10 is expressed similarly as in
lungs, and is localized to the mesenchyme adjacent to prostate
tips during postnatal branching (Bellusci et al., 1997; Donja-
cour et al., 2003). We have shown that BMP7 alone inhibited
Notch1/Hes1 activity in cultured urogenital sinus, while
explants grown in the presence of FGF10 maintained Hes1
Fig. 6. Model for branching morphogenesis in the prostate: (1) areas of high
Notch1/Hes1 activity are associated with forming prostate buds and with distal
tip epithelium; domains of low Notch1 activity are associated with interbud
epithelium and may contribute to proximal epithelial fates; (2) BMP7 signaling
inhibits formation of the new prostate buds, and limits the number of domains
with high Notch1 activity; (3) FGF10 may function to promote extension of the
prostate tips by favoring proliferation of the bud epithelium which exhibits high
Notch1 activity.
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data indicate that FGF10 can maintain activity of the Notch1
pathway downstream or independent of BMP7 signaling.
A model for relationship between branching morphogenesis
and proximal–distal cell fate choice
Since cell autonomous Notch1 activity is high in the initial
buds and at the distal prostate tips, we hypothesize that during
branching morphogenesis in the prostate Notch1/Hes1 activity
may define the epithelium of the prebud placode and the distal
epithelial fates. This hypothesis is in support of the studies of
Notch1 function in morphogenesis and cell fate specification in
the lungs, gut and pancreas. Constitutive Notch1 activity in the
pancreas has been shown to oppose proximal endocrine
differentiation while favoring maintenance of the progenitor
population and branching morphogenesis (Hald et al., 2003).
Deficiencies in the Notch pathway in Hes1/ lungs result in
broader domains of proximal epithelium with Dll1+ and
Mash1+ neuroendocrine fates (Ito et al., 2000). Similarly,
Hes1/ embryos show premature and excessive differentia-
tion of the proximal endocrine epithelium in the pancreas,
stomach and intestine (Jensen et al., 2000). Loss of Hes1
results in loss of enterocytes in the intestine, that compose the
distal epithelium of the villi, and causes hypoplasia in the
pancreas (de Santa Barbara et al., 2003; Jensen et al., 2000).
Thus, we suggest that in the urogenital and prostate epithelium,
as in other primitive gut derivatives, Notch1 activity suppresses
the proximal epithelial fates and favors distal outgrowth of the
epithelial ducts and distal fate specification.
During branching morphogenesis in the lung, the properties
of the distal epithelium include the ability to respond to FGF10
with increased cell proliferation and extension distally towards
the source of FGF10 (Weaver et al., 2000). In embryogenesis,
FGF10 is expressed in the distal mesenchyme of the urogenital
sinus and is required for the development of the prostate,
ampulatory and bulbourethral glands, and the seminal vesicles
(Donjacour et al., 2003). Our data indicate that FGF10
functions to maintain Notch1/Hes1 activity during prostate
development. FGF10 counteracted the inhibitory effect of
BMP7 on Hes1 expression during prostate growth in culture,
while urogenital explants treated with FGF10 alone maintained
Hes1 expression similar to that of untreated samples. Our data
are in support of the studies in pancreas, where FGF10 has
been suggested to promote survival and proliferation of the
pancreatic progenitor cells, which co-express Notch1,2 recep-
tors, the Notch ligands Jag1,2 and Hes1 (Hart et al., 2003;
Norgaard et al., 2003). We hypothesize that during branching
morphogenesis in the prostate FGF10 may function to maintain
the domains of high Notch1/Hes1 activity at the distal tip
epithelium, for instance, by promoting cell division in clusters
with high Notch1/Hes1 activity.
Based on our data and studies by others reviewed in this
section, we propose the following model to describe branching
morphogenesis in the mouse prostate gland (Fig. 6): (1) domains
of high Notch1 activity are associated with forming prostate
buds and with distal tip epithelium; domains of low Notch1activity are associated with interbud epithelium and may
contribute to proximal epithelial fates; (2) BMP7 signaling
inhibits formation of the new prostate buds, and limits the
number of domains with high Notch1 activity; (3) FGF10 may
function to promote extension of the prostate tips by favoring
proliferation of the bud epithelium which exhibits high Notch1
activity.
Relationship between BMP in prostate development
Combinatorial action and partial redundancy of function for
various BMPs has been suggested previously based on
heterodimer formation (Suzuki et al., 1997a,b), and on the
basis of early lethality of trans-heterozygous BMP4–BMP7
and BMP5–BMP7 mice (Katagiri et al., 1998; Solloway and
Robertson, 1999). It has been reported that haploinsufficiency
for BMP4 increases prostate branching (Lamm et al., 2001). In
addition, BMP7 and BMP4, and their respective receptors,
Alk2, Alk4 and Alk6, share partially overlapping expression in
the embryonic urogenital sinus and postnatal prostate (Lamm et
al., 2001; and this study). Thus, BMP4 and BMP7 may have
related and overlapping functions in regulation of prostate
branching. Yet, our analysis of prostate morphogenesis, and
pSmad1 and cNotch1 signaling in BMP7 null prostate gland,
allows to delineate the function of BMP7 in prostate
development. We show that increase in prostate branching in
BMP7 null prostates is accompanied with dramatic decrease in
pSmad1 signaling in the urogenital epithelium in spite of
presence of BMP4 in the mesenchyme (Lamm et al., 2001).
This indicates that BMP7 expressed in the periurethral
mesenchyme plays an essential role in prostate development.
We present evidence that Notch1 signaling becomes dere-
pressed in BMP7 null urogenital and prostate epithelium,
thereby showing that BMP7 signaling is essential for restricting
domains of Notch1 activity. At the same time, our data shows
that, in BMP7 null prostates, pSmad1 signaling is present at the
I.B. Grishina et al. / Developmental Biology 288 (2005) 334–347346distal tip epithelium, presumably reflecting BMP4 signaling
(Lamm et al., 2001). That corroborates the hypothesis that
BMP4 and BMP7 function in collaboration to restrict postnatal
prostate branching. Expression of BMP2 and BMP5 has also
been reported in the urogenital sinus and postnatal prostate
(King et al., 1994; Luo et al., 2002). BMP2, a close homologue
of BMP4, has been reported to affect branching morphogenesis
of the ureteric bud in culture (Bush et al., 2004). However,
BMP2 is expressed in the urogenital sinus at very low level
(Lamm et al., 2001) and, thus, it is unlikely to significantly
contribute to branching morphogenesis in the prostate. Expres-
sion of BMP5, a close homologue of BMP7, has been reported
in the mesenchyme adjacent to the bladder epithelium in
embryogenesis (King et al., 1994) and in the prostate
postnatally (Luo et al., 2002). Thus, future studies are needed
to determine the potential function of BMP5 and, possibly,
BMP2 in the development of the prostate, bladder and other
components of the lower urogenital system.
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